About this episode

This episode discusses strategies for implementing Antibody-Drug Conjugates in oncology nursing, featuring expert perspectives and insights.

Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics: Introduction (0:00) Overview of Antibody-Drug Conjugates (ADCs) (2:07) Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23) Currently Available ADCs for Gynecologic Cancer Management (26:37) Currently Available ADCs for Lung Cancer Management (44:07) Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55) Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07) Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01) NCPD information and select publications

More episodes of Lung Cancer Update

• HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · July 14, 2026 · 28 min
• Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft · July 11, 2026 · 60 min
• Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit · June 30, 2026 · 50 min
• EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit · June 27, 2026 · 51 min
• First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck · June 18, 2026 · 41 min

Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.